rs565033705

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_001036.6(RYR3):​c.2784-10T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000599 in 1,543,082 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00062 ( 11 hom. )

Consequence

RYR3
NM_001036.6 intron

Scores

3
Splicing: ADA: 0.009634
2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.08

Publications

0 publications found
Variant links:
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
RYR3 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, ClinGen, G2P
  • congenital myopathy
    Inheritance: AR Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001036.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 15-33631200-T-G is Benign according to our data. Variant chr15-33631200-T-G is described in ClinVar as Benign. ClinVar VariationId is 531146.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 11 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001036.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR3
NM_001036.6
MANE Select
c.2784-10T>G
intron
N/ANP_001027.3
RYR3
NM_001243996.4
c.2784-10T>G
intron
N/ANP_001230925.1Q15413-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR3
ENST00000634891.2
TSL:1 MANE Select
c.2784-10T>G
intron
N/AENSP00000489262.1Q15413-1
RYR3
ENST00000389232.9
TSL:5
c.2784-10T>G
intron
N/AENSP00000373884.5A0A0X1KG73
RYR3
ENST00000415757.7
TSL:2
c.2784-10T>G
intron
N/AENSP00000399610.3Q15413-2

Frequencies

GnomAD3 genomes
AF:
0.000407
AC:
62
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0126
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00133
AC:
253
AN:
190478
AF XY:
0.00191
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000363
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000200
GnomAD4 exome
AF:
0.000621
AC:
863
AN:
1390776
Hom.:
11
Cov.:
26
AF XY:
0.000935
AC XY:
645
AN XY:
689880
show subpopulations
African (AFR)
AF:
0.0000314
AC:
1
AN:
31890
American (AMR)
AF:
0.0000523
AC:
2
AN:
38270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37914
South Asian (SAS)
AF:
0.0103
AC:
820
AN:
79512
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51178
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5650
European-Non Finnish (NFE)
AF:
0.00000188
AC:
2
AN:
1063242
Other (OTH)
AF:
0.000638
AC:
37
AN:
58014
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
36
71
107
142
178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000407
AC:
62
AN:
152306
Hom.:
0
Cov.:
32
AF XY:
0.000591
AC XY:
44
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41576
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0126
AC:
61
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000128
Hom.:
1
Bravo
AF:
0.0000416
Asia WGS
AF:
0.00462
AC:
16
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Epileptic encephalopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
3.8
DANN
Benign
0.68
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0096
dbscSNV1_RF
Benign
0.21
SpliceAI score (max)
0.16
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs565033705;
hg19: chr15-33923401;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.